Natural Alpha Interferon as Part of a Combined Treatment for Small Cell Lung Cancer

  • Karin Mattson
Conference paper
Part of the ESO Monographs book series (ESO MONOGRAPHS)


In recent years, combined modality therapy with chemotherapy and radiotherapy has increased the 2-year survival figures of patients with small cell lung cancer (SCLC) (1). A clinical disease-free status is achieved in 20-40% of patients but this is followed by regrowth of the disease in the majority of patients due to drug resistance. There is a clear need to identify new systemic agents or new treatment strategies to further improve current results.


Small Cell Lung Cancer Induction Chemotherapy Radiation Pneumonitis Small Cell Lung Cancer Cell Combine Modality Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Morstyn G, Ihde D, Lichter A, Bunn P, Carney D, Glatstein E, Minna J: Int J Rad Oncol Biol Phys 1984Google Scholar
  2. 2.
    Oldham RK: Cancer Treat Rep 1984 (68):221–232PubMedGoogle Scholar
  3. 3.
    Mattson K, Holsti LR, Niiranen A, Kivisaari L, Iivanainen M, Sovijarvi A, Cantell K: J Biol Resp Mod if 1985 (4):8–17Google Scholar
  4. 4.
    Cantell K, Hirvonen S, Kauppinen HL, Myllyla G: Methods Enzymol 1981 (78):29PubMedCrossRefGoogle Scholar
  5. 5.
    Doyle A, Martin WJ, Funa K, Gazdar A, Carney D, Martin SE, Linnoila I, Cuttitta F, Mulshine S, Bunn P, Minna J: J Exp Med 1985(161)Google Scholar
  6. 6.
    Funa K, Gazdar A, Mattson Kt Niiranen A, Koivuniemi A, Oberg K, Wilander E, Doyle A, Linnoila I: N Engl J Med. In pressGoogle Scholar
  7. 7.
    Jones DH, Bleehen NM, Slater AJ, George PJM, Walker JR, Dixon AK: Br J Cancer 1983 (47):361PubMedCrossRefGoogle Scholar
  8. 8.
    Gresser I: Adv Cancer Res 1972 (16):97PubMedCrossRefGoogle Scholar
  9. 9.
    Mattson K, Niiranen A, Iivanainen M, Farkkila M, Bergstrom L, Holsti LR, Kauppinen HL, Cantell K: Cancer Treat Rep 1983 (67):958–961PubMedGoogle Scholar
  10. 10.
    Iivanainen M, Laaksonen R, Niemi ML, Farkkila M, Bergstrom L, Mattson K, Niiranen A, Cantell K: Acta Neurol Scand 1985 (72):475–480PubMedCrossRefGoogle Scholar
  11. 11.
    Mattson K, Holsti LR, Niiranen A, Kivisaari L, Iivanainen M, Sovijarvi A, Cantell K: J Biol Resp Modif 1985 (4):8–17Google Scholar
  12. 12.
    Holsti LR, Mattson K, Standertskiold-Nordenstam CG, Sovijarvi A, Stenman S, Cantell K: Int J Rad Oncol Biol Phys 1985. In pressGoogle Scholar
  13. 13.
    Niiranen A, Laaksonen R, In: Kirchner H, Schellekens H (eds) The Biology of the Interferon System. 1984:621–626Google Scholar
  14. 14.
    Knop R, Bunn P: Management of small cell lung cancer. In: Phillips T, Pisterman D (eds) Rad Oncol Ann. New York:Raven Press 1984Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • Karin Mattson
    • 1
  1. 1.Department of Pulmonary MedicineHelsinki University Central HospitalHelsinkiFinland

Personalised recommendations